Global Oral Direct Factor Xa Inhibitor Market Growth (Status and Outlook) 2025-2031

March 2025 | 95 pages | ID: G870B4AA96B0EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Oral Direct Factor Xa Inhibitor market size is predicted to grow from US$ 2554 million in 2025 to US$ 3501 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

Oral Direct Factor Xa Inhibitor is a type of medication that is taken orally (by mouth) and specifically designed to inhibit (block) the activity of Factor Xa, which is a key enzyme involved in the blood coagulation (clotting) process. By inhibiting Factor Xa, these inhibitors can effectively reduce the formation of blood clots, thereby lowering the risk of thromboembolic events (such as deep vein thrombosis and pulmonary embolism).

United States market for Oral Direct Factor Xa Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oral Direct Factor Xa Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oral Direct Factor Xa Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oral Direct Factor Xa Inhibitor players cover Bristol-Meyers Squibb Co, Pfizer, Boehringer Ingelheim Pharmaceuticals, Janssen Pharmaceuticals, Bayer AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Oral Direct Factor Xa Inhibitor Industry Forecast” looks at past sales and reviews total world Oral Direct Factor Xa Inhibitor sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Direct Factor Xa Inhibitor sales for 2025 through 2031. With Oral Direct Factor Xa Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Direct Factor Xa Inhibitor industry.

This Insight Report provides a comprehensive analysis of the global Oral Direct Factor Xa Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Direct Factor Xa Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Direct Factor Xa Inhibitor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Direct Factor Xa Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Direct Factor Xa Inhibitor.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Direct Factor Xa Inhibitor market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Apixaban
  • Dabigatran
  • Rivaroxaban
  • Edoxaban
Segmentation by Application:
  • Hospitals
  • Clinics
  • Pharmacy
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Bristol-Meyers Squibb Co
  • Pfizer
  • Boehringer Ingelheim Pharmaceuticals
  • Janssen Pharmaceuticals
  • Bayer AG
  • Teva Pharmaceutical Industries
  • Pab Organics Private Limited
  • Daiichi Sankyo Company
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Direct Factor Xa Inhibitor Market Size (2020-2031)
  2.1.2 Oral Direct Factor Xa Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Oral Direct Factor Xa Inhibitor by Country/Region (2020, 2024 & 2031)
2.2 Oral Direct Factor Xa Inhibitor Segment by Type
  2.2.1 Apixaban
  2.2.2 Dabigatran
  2.2.3 Rivaroxaban
  2.2.4 Edoxaban
2.3 Oral Direct Factor Xa Inhibitor Market Size by Type
  2.3.1 Oral Direct Factor Xa Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Oral Direct Factor Xa Inhibitor Market Size Market Share by Type (2020-2025)
2.4 Oral Direct Factor Xa Inhibitor Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Pharmacy
2.5 Oral Direct Factor Xa Inhibitor Market Size by Application
  2.5.1 Oral Direct Factor Xa Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Oral Direct Factor Xa Inhibitor Market Size Market Share by Application (2020-2025)

3 ORAL DIRECT FACTOR XA INHIBITOR MARKET SIZE BY PLAYER

3.1 Oral Direct Factor Xa Inhibitor Market Size Market Share by Player
  3.1.1 Global Oral Direct Factor Xa Inhibitor Revenue by Player (2020-2025)
  3.1.2 Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Player (2020-2025)
3.2 Global Oral Direct Factor Xa Inhibitor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL DIRECT FACTOR XA INHIBITOR BY REGION

4.1 Oral Direct Factor Xa Inhibitor Market Size by Region (2020-2025)
4.2 Global Oral Direct Factor Xa Inhibitor Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Direct Factor Xa Inhibitor Market Size Growth (2020-2025)
4.4 APAC Oral Direct Factor Xa Inhibitor Market Size Growth (2020-2025)
4.5 Europe Oral Direct Factor Xa Inhibitor Market Size Growth (2020-2025)
4.6 Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025)
5.2 Americas Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025)
5.3 Americas Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Direct Factor Xa Inhibitor Market Size by Region (2020-2025)
6.2 APAC Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025)
6.3 APAC Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025)
7.2 Europe Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025)
7.3 Europe Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Direct Factor Xa Inhibitor by Region (2020-2025)
8.2 Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025)
8.3 Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL DIRECT FACTOR XA INHIBITOR MARKET FORECAST

10.1 Global Oral Direct Factor Xa Inhibitor Forecast by Region (2026-2031)
  10.1.1 Global Oral Direct Factor Xa Inhibitor Forecast by Region (2026-2031)
  10.1.2 Americas Oral Direct Factor Xa Inhibitor Forecast
  10.1.3 APAC Oral Direct Factor Xa Inhibitor Forecast
  10.1.4 Europe Oral Direct Factor Xa Inhibitor Forecast
  10.1.5 Middle East & Africa Oral Direct Factor Xa Inhibitor Forecast
10.2 Americas Oral Direct Factor Xa Inhibitor Forecast by Country (2026-2031)
  10.2.1 United States Market Oral Direct Factor Xa Inhibitor Forecast
  10.2.2 Canada Market Oral Direct Factor Xa Inhibitor Forecast
  10.2.3 Mexico Market Oral Direct Factor Xa Inhibitor Forecast
  10.2.4 Brazil Market Oral Direct Factor Xa Inhibitor Forecast
10.3 APAC Oral Direct Factor Xa Inhibitor Forecast by Region (2026-2031)
  10.3.1 China Oral Direct Factor Xa Inhibitor Market Forecast
  10.3.2 Japan Market Oral Direct Factor Xa Inhibitor Forecast
  10.3.3 Korea Market Oral Direct Factor Xa Inhibitor Forecast
  10.3.4 Southeast Asia Market Oral Direct Factor Xa Inhibitor Forecast
  10.3.5 India Market Oral Direct Factor Xa Inhibitor Forecast
  10.3.6 Australia Market Oral Direct Factor Xa Inhibitor Forecast
10.4 Europe Oral Direct Factor Xa Inhibitor Forecast by Country (2026-2031)
  10.4.1 Germany Market Oral Direct Factor Xa Inhibitor Forecast
  10.4.2 France Market Oral Direct Factor Xa Inhibitor Forecast
  10.4.3 UK Market Oral Direct Factor Xa Inhibitor Forecast
  10.4.4 Italy Market Oral Direct Factor Xa Inhibitor Forecast
  10.4.5 Russia Market Oral Direct Factor Xa Inhibitor Forecast
10.5 Middle East & Africa Oral Direct Factor Xa Inhibitor Forecast by Region (2026-2031)
  10.5.1 Egypt Market Oral Direct Factor Xa Inhibitor Forecast
  10.5.2 South Africa Market Oral Direct Factor Xa Inhibitor Forecast
  10.5.3 Israel Market Oral Direct Factor Xa Inhibitor Forecast
  10.5.4 Turkey Market Oral Direct Factor Xa Inhibitor Forecast
10.6 Global Oral Direct Factor Xa Inhibitor Forecast by Type (2026-2031)
10.7 Global Oral Direct Factor Xa Inhibitor Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Oral Direct Factor Xa Inhibitor Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bristol-Meyers Squibb Co
  11.1.1 Bristol-Meyers Squibb Co Company Information
  11.1.2 Bristol-Meyers Squibb Co Oral Direct Factor Xa Inhibitor Product Offered
  11.1.3 Bristol-Meyers Squibb Co Oral Direct Factor Xa Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bristol-Meyers Squibb Co Main Business Overview
  11.1.5 Bristol-Meyers Squibb Co Latest Developments
11.2 Pfizer
  11.2.1 Pfizer Company Information
  11.2.2 Pfizer Oral Direct Factor Xa Inhibitor Product Offered
  11.2.3 Pfizer Oral Direct Factor Xa Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Pfizer Main Business Overview
  11.2.5 Pfizer Latest Developments
11.3 Boehringer Ingelheim Pharmaceuticals
  11.3.1 Boehringer Ingelheim Pharmaceuticals Company Information
  11.3.2 Boehringer Ingelheim Pharmaceuticals Oral Direct Factor Xa Inhibitor Product Offered
  11.3.3 Boehringer Ingelheim Pharmaceuticals Oral Direct Factor Xa Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview
  11.3.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
11.4 Janssen Pharmaceuticals
  11.4.1 Janssen Pharmaceuticals Company Information
  11.4.2 Janssen Pharmaceuticals Oral Direct Factor Xa Inhibitor Product Offered
  11.4.3 Janssen Pharmaceuticals Oral Direct Factor Xa Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Janssen Pharmaceuticals Main Business Overview
  11.4.5 Janssen Pharmaceuticals Latest Developments
11.5 Bayer AG
  11.5.1 Bayer AG Company Information
  11.5.2 Bayer AG Oral Direct Factor Xa Inhibitor Product Offered
  11.5.3 Bayer AG Oral Direct Factor Xa Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Bayer AG Main Business Overview
  11.5.5 Bayer AG Latest Developments
11.6 Teva Pharmaceutical Industries
  11.6.1 Teva Pharmaceutical Industries Company Information
  11.6.2 Teva Pharmaceutical Industries Oral Direct Factor Xa Inhibitor Product Offered
  11.6.3 Teva Pharmaceutical Industries Oral Direct Factor Xa Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Teva Pharmaceutical Industries Main Business Overview
  11.6.5 Teva Pharmaceutical Industries Latest Developments
11.7 Pab Organics Private Limited
  11.7.1 Pab Organics Private Limited Company Information
  11.7.2 Pab Organics Private Limited Oral Direct Factor Xa Inhibitor Product Offered
  11.7.3 Pab Organics Private Limited Oral Direct Factor Xa Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Pab Organics Private Limited Main Business Overview
  11.7.5 Pab Organics Private Limited Latest Developments
11.8 Daiichi Sankyo Company
  11.8.1 Daiichi Sankyo Company Company Information
  11.8.2 Daiichi Sankyo Company Oral Direct Factor Xa Inhibitor Product Offered
  11.8.3 Daiichi Sankyo Company Oral Direct Factor Xa Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Daiichi Sankyo Company Main Business Overview
  11.8.5 Daiichi Sankyo Company Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Oral Direct Factor Xa Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oral Direct Factor Xa Inhibitor Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Apixaban
Table 4. Major Players of Dabigatran
Table 5. Major Players of Rivaroxaban
Table 6. Major Players of Edoxaban
Table 7. Oral Direct Factor Xa Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Oral Direct Factor Xa Inhibitor Market Size Market Share by Type (2020-2025)
Table 10. Oral Direct Factor Xa Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Oral Direct Factor Xa Inhibitor Market Size Market Share by Application (2020-2025)
Table 13. Global Oral Direct Factor Xa Inhibitor Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Player (2020-2025)
Table 15. Oral Direct Factor Xa Inhibitor Key Players Head office and Products Offered
Table 16. Oral Direct Factor Xa Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oral Direct Factor Xa Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Oral Direct Factor Xa Inhibitor Market Size Market Share by Region (2020-2025)
Table 21. Global Oral Direct Factor Xa Inhibitor Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Oral Direct Factor Xa Inhibitor Market Size Market Share by Country (2020-2025)
Table 25. Americas Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Oral Direct Factor Xa Inhibitor Market Size Market Share by Type (2020-2025)
Table 27. Americas Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Oral Direct Factor Xa Inhibitor Market Size Market Share by Application (2020-2025)
Table 29. APAC Oral Direct Factor Xa Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Oral Direct Factor Xa Inhibitor Market Size Market Share by Region (2020-2025)
Table 31. APAC Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Oral Direct Factor Xa Inhibitor Market Size Market Share by Country (2020-2025)
Table 35. Europe Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Oral Direct Factor Xa Inhibitor
Table 41. Key Market Challenges & Risks of Oral Direct Factor Xa Inhibitor
Table 42. Key Industry Trends of Oral Direct Factor Xa Inhibitor
Table 43. Global Oral Direct Factor Xa Inhibitor Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Oral Direct Factor Xa Inhibitor Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Oral Direct Factor Xa Inhibitor Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Oral Direct Factor Xa Inhibitor Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Bristol-Meyers Squibb Co Details, Company Type, Oral Direct Factor Xa Inhibitor Area Served and Its Competitors
Table 48. Bristol-Meyers Squibb Co Oral Direct Factor Xa Inhibitor Product Offered
Table 49. Bristol-Meyers Squibb Co Oral Direct Factor Xa Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Bristol-Meyers Squibb Co Main Business
Table 51. Bristol-Meyers Squibb Co Latest Developments
Table 52. Pfizer Details, Company Type, Oral Direct Factor Xa Inhibitor Area Served and Its Competitors
Table 53. Pfizer Oral Direct Factor Xa Inhibitor Product Offered
Table 54. Pfizer Oral Direct Factor Xa Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Boehringer Ingelheim Pharmaceuticals Details, Company Type, Oral Direct Factor Xa Inhibitor Area Served and Its Competitors
Table 58. Boehringer Ingelheim Pharmaceuticals Oral Direct Factor Xa Inhibitor Product Offered
Table 59. Boehringer Ingelheim Pharmaceuticals Oral Direct Factor Xa Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Boehringer Ingelheim Pharmaceuticals Main Business
Table 61. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 62. Janssen Pharmaceuticals Details, Company Type, Oral Direct Factor Xa Inhibitor Area Served and Its Competitors
Table 63. Janssen Pharmaceuticals Oral Direct Factor Xa Inhibitor Product Offered
Table 64. Janssen Pharmaceuticals Oral Direct Factor Xa Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Janssen Pharmaceuticals Main Business
Table 66. Janssen Pharmaceuticals Latest Developments
Table 67. Bayer AG Details, Company Type, Oral Direct Factor Xa Inhibitor Area Served and Its Competitors
Table 68. Bayer AG Oral Direct Factor Xa Inhibitor Product Offered
Table 69. Bayer AG Oral Direct Factor Xa Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Bayer AG Main Business
Table 71. Bayer AG Latest Developments
Table 72. Teva Pharmaceutical Industries Details, Company Type, Oral Direct Factor Xa Inhibitor Area Served and Its Competitors
Table 73. Teva Pharmaceutical Industries Oral Direct Factor Xa Inhibitor Product Offered
Table 74. Teva Pharmaceutical Industries Oral Direct Factor Xa Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Teva Pharmaceutical Industries Main Business
Table 76. Teva Pharmaceutical Industries Latest Developments
Table 77. Pab Organics Private Limited Details, Company Type, Oral Direct Factor Xa Inhibitor Area Served and Its Competitors
Table 78. Pab Organics Private Limited Oral Direct Factor Xa Inhibitor Product Offered
Table 79. Pab Organics Private Limited Oral Direct Factor Xa Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Pab Organics Private Limited Main Business
Table 81. Pab Organics Private Limited Latest Developments
Table 82. Daiichi Sankyo Company Details, Company Type, Oral Direct Factor Xa Inhibitor Area Served and Its Competitors
Table 83. Daiichi Sankyo Company Oral Direct Factor Xa Inhibitor Product Offered
Table 84. Daiichi Sankyo Company Oral Direct Factor Xa Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Daiichi Sankyo Company Main Business
Table 86. Daiichi Sankyo Company Latest Developments



LIST OF FIGURES

Figure 1. Oral Direct Factor Xa Inhibitor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Direct Factor Xa Inhibitor Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oral Direct Factor Xa Inhibitor Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oral Direct Factor Xa Inhibitor Sales Market Share by Country/Region (2024)
Figure 8. Oral Direct Factor Xa Inhibitor Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oral Direct Factor Xa Inhibitor Market Size Market Share by Type in 2024
Figure 10. Oral Direct Factor Xa Inhibitor in Hospitals
Figure 11. Global Oral Direct Factor Xa Inhibitor Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Oral Direct Factor Xa Inhibitor in Clinics
Figure 13. Global Oral Direct Factor Xa Inhibitor Market: Clinics (2020-2025) & ($ millions)
Figure 14. Oral Direct Factor Xa Inhibitor in Pharmacy
Figure 15. Global Oral Direct Factor Xa Inhibitor Market: Pharmacy (2020-2025) & ($ millions)
Figure 16. Global Oral Direct Factor Xa Inhibitor Market Size Market Share by Application in 2024
Figure 17. Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Player in 2024
Figure 18. Global Oral Direct Factor Xa Inhibitor Market Size Market Share by Region (2020-2025)
Figure 19. Americas Oral Direct Factor Xa Inhibitor Market Size 2020-2025 ($ millions)
Figure 20. APAC Oral Direct Factor Xa Inhibitor Market Size 2020-2025 ($ millions)
Figure 21. Europe Oral Direct Factor Xa Inhibitor Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size 2020-2025 ($ millions)
Figure 23. Americas Oral Direct Factor Xa Inhibitor Value Market Share by Country in 2024
Figure 24. United States Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Oral Direct Factor Xa Inhibitor Market Size Market Share by Region in 2024
Figure 29. APAC Oral Direct Factor Xa Inhibitor Market Size Market Share by Type (2020-2025)
Figure 30. APAC Oral Direct Factor Xa Inhibitor Market Size Market Share by Application (2020-2025)
Figure 31. China Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 35. India Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Oral Direct Factor Xa Inhibitor Market Size Market Share by Country in 2024
Figure 38. Europe Oral Direct Factor Xa Inhibitor Market Size Market Share by Type (2020-2025)
Figure 39. Europe Oral Direct Factor Xa Inhibitor Market Size Market Share by Application (2020-2025)
Figure 40. Germany Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 41. France Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Oral Direct Factor Xa Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 54. APAC Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 55. Europe Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 57. United States Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 58. Canada Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 59. Mexico Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 60. Brazil Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 61. China Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 62. Japan Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 63. Korea Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 65. India Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 66. Australia Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 67. Germany Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 68. France Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 69. UK Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 70. Italy Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 71. Russia Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 72. Egypt Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 73. South Africa Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 74. Israel Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 75. Turkey Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)
Figure 76. Global Oral Direct Factor Xa Inhibitor Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Oral Direct Factor Xa Inhibitor Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Oral Direct Factor Xa Inhibitor Market Size 2026-2031 ($ millions)